Here, we have confirmed through in vitro experiments that overexpressing TCF12 promotes cell proliferation, invasion and EMT, weakens apoptosis, and activates the PI3K/AKT signaling pathway in glioma. The gene discussed is TCF12; the disease is central nervous system cancer.